BioMaterials Next
BioMaterials Next Raises $460M Series C to Revolutionize Materials Science
BioMaterials Next
Revolutionary bio-based materials engineering spider silk proteins and mycelium for sustainable alternatives to plastics, leather, and steel.
About the Funding
BioMaterials Next has successfully raised $460M in a Series C funding round, bringing their total valuation to $6.2B. This significant investment will fuel the company's mission to scale biomanufacturing facilities, advance material properties research, and establish partnerships with fashion and automotive industries.
Use of Funds
Scale biomanufacturing facilities, advance material properties research, and establish partnerships with fashion and automotive industries
Company Overview
Revolutionary bio-based materials engineering spider silk proteins and mycelium for sustainable alternatives to plastics, leather, and steel.
Market Opportunity
The materials science market is experiencing unprecedented growth in 2025, with increasing demand for innovative solutions that revolutionary bio-based materials engineering spider silk proteins and mycelium for sustainable alternatives to plastics, leather, and steel.. BioMaterials Next is positioned to capture significant market share through their differentiated technology platform and strategic partnerships.
Key Investors
- • BASF Ventures
- • DSM Venturing
- • Patagonia Ventures
- • Material Impact Fund
Founders
- • Dr. Bio Material
- • Spider Silk Engineer
Previous Rounds
Investment Highlights
Technology Innovation
BioMaterials Next has developed breakthrough technology that addresses key market challenges and provides significant competitive advantages in the materials science space.
Market Traction
Strong customer adoption and revenue growth demonstrate market validation and scalability potential for BioMaterials Next's innovative solutions.
Team Excellence
Led by experienced founders with deep domain expertise, BioMaterials Next has assembled a world-class team capable of executing on ambitious growth plans.
Strategic Partnerships
Strong investor syndicate and strategic partnerships provide BioMaterials Next with the resources and market access needed for global expansion.
Looking Forward
With this $460M investment, BioMaterials Next is well-positioned to accelerate growth, expand market presence, and continue innovation in the materials science sector. The funding will enable the company to achieve key milestones and establish market leadership while delivering exceptional value to customers and stakeholders.
Company Info
Investors (4)
Share
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free